Zacks: Analysts Expect iRobot Co. (NASDAQ:IRBT) to Announce $0.03 EPS

Brokerages expect iRobot Co. (NASDAQ:IRBT) to announce $0.03 earnings per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for iRobot’s earnings, with the highest EPS estimate coming in at $0.22 and the lowest estimate coming in at ($0.07). iRobot posted earnings of $0.37 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 91.9%. The business is scheduled to issue its next earnings results after the market closes on Tuesday, July 23rd.

According to Zacks, analysts expect that iRobot will report full-year earnings of $3.13 per share for the current fiscal year, with EPS estimates ranging from $2.76 to $3.30. For the next fiscal year, analysts forecast that the company will report earnings of $3.74 per share, with EPS estimates ranging from $3.44 to $4.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow iRobot.

iRobot (NASDAQ:IRBT) last posted its quarterly earnings data on Tuesday, April 23rd. The industrial products company reported $0.84 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.16. The company had revenue of $237.66 million during the quarter, compared to analysts’ expectations of $251.40 million. iRobot had a net margin of 8.09% and a return on equity of 17.64%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.71 earnings per share.

A number of equities analysts have weighed in on IRBT shares. Citigroup set a $95.00 price objective on shares of iRobot and gave the stock a “hold” rating in a research report on Wednesday, July 3rd. JPMorgan Chase & Co. set a €8.75 ($10.17) price objective on shares of Commerzbank and gave the stock a “buy” rating in a research report on Thursday, April 18th. Zacks Investment Research cut shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, June 26th. Northland Securities restated a “buy” rating and set a $130.00 price objective on shares of iRobot in a research report on Wednesday. Finally, ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. iRobot has a consensus rating of “Hold” and a consensus target price of $109.36.

NASDAQ:IRBT traded down $1.88 during trading hours on Friday, reaching $91.70. 18,706 shares of the company were exchanged, compared to its average volume of 500,642. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.97 and a current ratio of 3.22. The stock has a 50-day moving average of $90.20. The firm has a market cap of $2.57 billion, a price-to-earnings ratio of 21.13, a PEG ratio of 1.43 and a beta of 1.61. iRobot has a twelve month low of $70.86 and a twelve month high of $132.88.

In related news, Director Andrew Miller sold 878 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $91.97, for a total value of $80,749.66. Following the completion of the sale, the director now owns 14,199 shares of the company’s stock, valued at $1,305,882.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Russell J. Campanello sold 11,159 shares of the company’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $95.00, for a total transaction of $1,060,105.00. Following the completion of the sale, the executive vice president now directly owns 28,791 shares of the company’s stock, valued at approximately $2,735,145. The disclosure for this sale can be found here. Insiders sold 23,693 shares of company stock valued at $2,156,268 in the last three months. 3.01% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Osborn Williams & Donohoe LLC purchased a new stake in shares of iRobot in the first quarter valued at about $29,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in iRobot by 16.7% during the first quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 700 shares of the industrial products company’s stock worth $82,000 after buying an additional 100 shares during the period. American Research & Management Co. purchased a new position in iRobot during the first quarter worth about $118,000. Lakeview Capital Partners LLC purchased a new position in iRobot during the first quarter worth about $202,000. Finally, First Republic Investment Management Inc. purchased a new position in iRobot during the first quarter worth about $223,000. 97.16% of the stock is owned by hedge funds and other institutional investors.

iRobot Company Profile

iRobot Corporation designs, builds, and sells robots for the consumer market worldwide. It offers Roomba floor vacuuming robots; Braava family of automatic floor mopping robots; and Mirra Pool Cleaning Robot to clean residential pools and removes debris as small as two microns from pool floors, walls, and stairs.

Recommended Story: What does it mean to hold a stock in street name?

Get a free copy of the Zacks research report on iRobot (IRBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for iRobot (NASDAQ:IRBT)

Receive News & Ratings for iRobot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRobot and related companies with MarketBeat.com's FREE daily email newsletter.